Alexithymia, the inability to identify or label emotions, has been shown to be associated with pain in patients with a number of chronic pain conditions. We sought to: (1) replicate this association in samples of persons with chronic pain secondary to neuromuscular disease, (2) extend this finding to other important pain-related measures, and (3) to determine whether relationships among alexithymia and study variables existed after controlling for negative affect. One hundred and twenty-nine individuals with muscular dystrophy and chronic pain were administered measures of alexithymia (Toronto Alexithymia Scale, TAS-20), pain intensity (0-10 NRS), pain interference (Brief Pain Inventory Interference scale), mental health (SF-36 Mental Health scale; as a proxy measure of negative affect) and vitality (SF-36 Vitality scale). Higher TAS scores were associated significantly with higher pain intensity and interference, and less vitality. Although the strengths of these associations were reduced when mental health was used as a control, the associations between the Difficulty Identifying Feelings scale and vitality, and the Externally Oriented Thinking and Total TAS scales and pain intensity remained statistically significant. The findings replicate and extend previous findings concerning the associations between alexithymia and important pain-related variables in a sample of persons with chronic pain and neuromuscular disease. Future research is needed to determine the extent to which the associations are due to (1) a possible causal effect of alexithymia on patient functioning that is mediated via its effects on negative affect or (2) the possibility that alexithymia/outcome relationships reflect response bias caused by general negative affectivity.
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Introduction
The concept of alexithymia, a lack of emotional awareness and ability to describe feelings, was originally coined by Sifneos [33] to describe a common characteristic of patients with psychosomatic illness. Some authors have suggested that having alexithymia can contribute to the future development or maintenance of psychosomatic illness, that is, medical disorders thought to be primarily caused or maintained by psychological factors [1, 3] . Consistent with this hypothesis, research has supported the notion that patients with psychosomatic illnesses, such as asthma, hypertension, and functional bowel syndromes report higher levels of alexithymia than healthy controls [10] . Moreover, alexithymia has been shown to prospectively predict the maintenance of somatization over a period of 2 years [3] .
Alexithymia has been shown to be associated with pain in patients with chronic myofascial pain [25] Although alexithymia has been shown to be associated with a range of negative outcomes, some debate exists as to the mechanism of these associations, particularly when considering psychological outcomes such as negative affect. For example, it has been
